JAZZ News and Press, Jazz Pharmaceuticals plc From 05/26/22

Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis, Alzheimer’s, Parkinson’s, among others. Accordin...

Jazz Pharmaceuticals to Present Data Showcasing Clinical Advancements Across Oncology Portfolio at 2022 ASCO and EHA Meetings PR Newswire Key data includes ASCO oral presentation of data from the Rylaze ® (asparaginase erwinia chrysanthemi (recombinant)-rywn) ...

Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea PR Newswire Axsome is committed to providing patients uninterrupted access to Sunosi and advancing resea...

The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2022 Q1 earnings call. For further details see: Jazz Pharmaceuticals plc 2022 Q1 - Results - Earnings Call Presentation

Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics PR Newswire DUBLIN , May 9, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has completed the divestiture of Sunosi ...

Jazz Pharmaceuticals (NASDAQ:JAZZ) and Japan's Sumitomo Pharma entered into a licensing agreement under which Jazz acquired the rights to make and sell Sumitomo's investigational compound DSP-0187, which has the potential to treat narcolepsy, idiopathic hypersomnia and other sleep disorders. ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced financial results for the first quarter of 2022, raised 2022 financial guidance, and provided business updates. “We’re pleased to raise our top- and bottom-line guidance, driven by our continued execution and ...

THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and eve appetite, weight/BMI. In fact, in a study of 900 adults aged 21 and older in the U.S., InMed Pharmaceuticals Inc.’s (NASDAQ: INM) subsidiary, BayMedica, will be providing rare can...

Top Marijuana Stocks To Watch That May Be Overlooked By Investors Are marijuana stocks investors going to go back to fundamental trading. Right now there is a lot in the works for the cannabis industry as a whole. Many cannabis companies have released solid earnings over the last mo...

Jazz Pharmaceuticals plc (JAZZ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Andrea Flynn – Head-Investor Relations Bruce Cozadd – Chairman and Chief Executive Officer Dan Swisher – President Rob Iannone – Executive Vice President, G...